Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Credits Drug Industry With 2.7 Mil. U.S. Jobs

This article was originally published in The Pink Sheet Daily

Executive Summary

Study commissioned by the trade association finds that “multiplicative” effects of every biopharmaceutical job lead to 5.7 other jobs. Industry’s weight in domestic job creation underscores the need to avoid drug price controls and importation proposals, PhRMA argues.

You may also be interested in...



J&J Will "Repatriate" Up To $10 Bil. In Foreign-Held Cash If Bill Is Signed

Company expects to spend about $350 mil. to $500 mil. to bring the foreign-held cash to U.S.-based accounts. Cash might be used to fund pipeline. J&J continues to work toward achieving $1 bil. annual cost savings.

J&J Will "Repatriate" Up To $10 Bil. In Foreign-Held Cash If Bill Is Signed

Company expects to spend about $350 mil. to $500 mil. to bring the foreign-held cash to U.S.-based accounts. Cash might be used to fund pipeline. J&J continues to work toward achieving $1 bil. annual cost savings.

Rx “Tax Holiday” Nears President’s Desk Following House Passage

A tax change that would allow U.S. pharmaceutical companies to pay a far lower duty to "repatriate" up to $500 mil. claimed by overseas affiliates remains en route to becoming law, despite objections raised by the Bush Administration

Topics

UsernamePublicRestriction

Register

MT003605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel